# 18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

> **NCT01825902** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 1 (actual)

## Conditions studied

- Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)
- Ewing Sarcoma of Bone
- Extraosseous Ewing Sarcoma
- Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor

## Interventions

- **DRUG:** fluorine F 18 fluorothymidine
- **RADIATION:** fludeoxyglucose F 18
- **PROCEDURE:** positron emission tomography
- **PROCEDURE:** diffusion-weighted magnetic resonance imaging
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01825902
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-01
- **Final completion:** 2015-11-23
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825902, "18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01825902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*